Andere Sprachen Vericel Corporation

Aktien

A12FU4

US92346J1088

VCEL

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 02.05.2024			% 5 Tage	% 1. Jan.
47.88 ^USD	+1.70%		+5.35%	+34.46%

19.04.	Vericel-Insider verkauft Aktien im Wert von $1.593.550, laut einer aktuellen SEC-Einreichung	MT
15.03.	Vericel-Insider verkauft Aktien im Wert von $1.552.075, laut einer aktuellen SEC-Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024	24.04.
Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing	19.04.
Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing	15.03.
Vericel Insider Sold Shares Worth $352,047, According to a Recent SEC Filing	13.03.
Vericel Insider Sold Shares Worth $367,853, According to a Recent SEC Filing	11.03.
Vericel Q4 EPS, Revenue Increase; Issues 2024 Outlook -- Shares Rise Pre-Bell	29.02.
Vericel Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Vericel Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29.02.
Vericel Corporation Provides Earnings Guidance for the Fiscal Year 2024	29.02.
Earnings Flash (VCEL) VERICEL CORPORATION Reports Q4 Revenue $65M, vs. Street Est of $64M	29.02.
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance	29.02.
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance	29.02.
North American Morning Briefing : Fed's Preferred -2-	29.02.
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024	27.02.
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024	27.02.
Vericel Insider Sold Shares Worth $1,677,200, According to a Recent SEC Filing	16.02.
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024	15.02.
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024	15.02.
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024	05.02.
North American Morning Briefing : Intel Drags Down -2-	26.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Vericel Corporation

Aktien

A12FU4

US92346J1088

VCEL

Andere Sprachen

Filter